Page last updated: 2024-11-07

pilocarpine and Stevens-Johnson Syndrome

pilocarpine has been researched along with Stevens-Johnson Syndrome in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavan-Langston, D1

Other Studies

1 other study available for pilocarpine and Stevens-Johnson Syndrome

ArticleYear
Potential use of ocular-insert therapy in dry eyes.
    International ophthalmology clinics, 1973,Spring, Volume: 13, Issue:1

    Topics: Burns, Chemical; Dosage Forms; Eye Burns; Eye Diseases; Glaucoma; Graft Rejection; Humans; Hydrocort

1973